ZNF268 was described as chronic lymphocytic leukemia (CLL)-associated antigen (Krackhardt et al., 2002), its aberrant alternative splicing was detected in human hematological malignancies (Zhao et al., 2008). The gene discussed is ZNF268; the disease is B-cell chronic lymphocytic leukemia.